Phong Phu Pharmaceutical JSC (HNX:PPP)

HNX:PPP Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4,393	9,540	8,876	8,482	10,301	12,118
Short-Term Investments	43,372	40,084	31,108	23,563	16,000	6,000
Cash & Short-Term Investments	47,765	49,624	39,984	32,044	26,301	18,118
Cash Growth	59.66%	24.11%	24.78%	21.84%	45.16%	101.10%
Accounts Receivable	9,753	7,508	11,094	13,188	13,568	10,446
Other Receivables	2,137	1,174	611.26	860.07	612.57	321.78
Receivables	11,891	8,682	11,705	14,048	14,181	10,768
Inventory	42,632	40,064	36,899	32,000	36,759	41,533
Prepaid Expenses	-	289.45	387.27	241.55	157.02	192.73
Other Current Assets	1,874	1,720	2,252	1,311	1,074	163.62
Total Current Assets	104,161	100,379	91,228	79,644	78,472	70,775
Property, Plant & Equipment	56,591	56,184	57,498	60,464	60,239	64,374
Other Intangible Assets	15,873	16,171	16,851	17,548	18,244	18,941
Long-Term Deferred Tax Assets	633.32	787.19	468.27	330.04	474.71	587.83
Other Long-Term Assets	3,003	3,200	1,097	2,036	763.99	1,352
Total Assets	180,262	176,721	167,142	160,022	158,194	156,030

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Accounts Payable	12,008	10,230	13,502	11,688	12,642	16,378
Accrued Expenses	14,874	14,258	10,963	10,912	9,175	7,455
Short-Term Debt	1,316	6,287	-	-	-	2,000
Current Income Taxes Payable	-	1,523	1,404	1,271	2,261	896.66
Other Current Liabilities	8,325	5,488	5,699	5,556	9,275	12,492
Total Current Liabilities	36,523	37,786	31,567	29,426	33,354	39,222
Other Long-Term Liabilities	199	205.5	217	225	225	225
Total Liabilities	36,722	37,992	31,784	29,651	33,579	39,447

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Common Stock	88,000	88,000	88,000	88,000	88,000	88,000
Additional Paid-In Capital	2,206	2,206	2,206	2,206	2,206	2,206
Retained Earnings	53,334	48,524	45,153	40,165	34,410	26,378
Shareholders' Equity	143,540	138,729	135,358	130,371	124,616	116,583
Total Liabilities & Equity	180,262	176,721	167,142	160,022	158,194	156,030

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Total Debt	1,316	6,287	-	-	-	2,000
Net Cash (Debt)	46,449	43,337	39,984	32,044	26,301	16,118
Net Cash Growth	68.07%	8.38%	24.78%	21.84%	63.18%	-
Net Cash Per Share	5310.35	4924.64	4543.68	3641.42	2694.95	1645.87
Filing Date Shares Outstanding	9.72	8.8	8.8	7.85	8.8	9.76
Total Common Shares Outstanding	9.72	8.8	8.8	7.85	8.8	9.76
Working Capital	67,638	62,593	59,660	50,218	45,119	31,554
Book Value Per Share	14772.47	15764.73	15381.62	16605.35	14160.89	11943.46
Tangible Book Value	127,667	122,558	118,507	112,823	106,371	97,642
Tangible Book Value Per Share	13138.91	13927.11	13466.74	14370.30	12087.67	10003.03
Buildings	-	68,337	67,996	67,996	-	-
Machinery	-	45,347	43,401	43,710	-	-
Construction In Progress	2.48	-	61.78	-	575.07	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error